1. Effect of structured use of preoperative portal vein embolization on outcomes after liver resection of perihilar cholangiocarcinoma
- Author
-
Franken, L.C. (L. C.), Rassam, F. (F.), van Lienden, K.P. (K. P.), Bennink, R.J. (Roelof), Besselink, M.G. (Marc), Busch, O.R.C. (Olivier), Erdmann, J.I. (Joris), Gulik, T.M. (Thomas) van, Olthof, P.B. (P. B.), Franken, L.C. (L. C.), Rassam, F. (F.), van Lienden, K.P. (K. P.), Bennink, R.J. (Roelof), Besselink, M.G. (Marc), Busch, O.R.C. (Olivier), Erdmann, J.I. (Joris), Gulik, T.M. (Thomas) van, and Olthof, P.B. (P. B.)
- Abstract
BACKGROUND: Portal vein embolization (PVE) is performed to reduce the risk of liver failure and subsequent mortality after major liver resection. Although a cut-off value of 2·7 per cent per min per m2 has been used with hepatobiliary scintigraphy (HBS) for future remnant liver function (FRLF), patients with perihilar cholangiocarcinoma (PHC) potentially benefit from an additional cut-off of 8·5 per cent/min (not corrected for body surface area). Since January 2016 a more liberal approach to PVE has been adopted, including this additional cut-off for HBS of 8·5 per cent/min. The aim of this study was to assess the effect of this approach on liver failure and mortality. METHODS: This was a single-centre retrospective study in which consecutive patients undergoing liver resection under suspicion of PHC in 2000-201
- Published
- 2020
- Full Text
- View/download PDF